Oncology Drugs Market Size to Surpass USD 530.39 Billion by 2032, Driven by Advancements in Targeted Therapies and Rising Cancer Incidence – SNS Insider [Yahoo! Finance]
PESG Report: Silexion Therapeutics' Breakthrough Data Shows SIL204's impact on both Primary Tumors & Metastasis – Signaling a Potential Paradigm Shift in Cancer Treatment [Yahoo! Finance]
AbbVie reports final analysis from Phase III trial of Elahere for ovarian cancer [Yahoo! Finance]
1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction [Yahoo! Finance]
ELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients